MicroPort MedBot

MicroPort MedBot is a China-based publicly traded medical technology company focused on the research, development, manufacturing, and commercialization of surgical robotic systems. The company is building a broad surgical robotics portfolio spanning laparoscopic, orthopedic, panvascular, natural-orifice, and percutaneous procedures, with flagship products including the Toumai laparoscopic robot and SkyWalker orthopedic robot. It positions itself as an intelligent surgery platform provider combining robot ontology, control algorithms, image-based navigation, precision imaging, and telesurgery capabilities. MedBot has obtained multiple regulatory clearances, including NMPA approvals and selected FDA/CE clearances for parts of its portfolio, and has expanded commercialization into numerous international markets. The business is best understood as a medtech robotics company rather than a drug developer, so traditional biotech pipeline concepts such as molecular targets and therapeutic modalities are generally not applicable.